pubmed-article:10921574 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C0019080 | lld:lifeskim |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C0699819 | lld:lifeskim |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C0035273 | lld:lifeskim |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:10921574 | lifeskim:mentions | umls-concept:C0041281 | lld:lifeskim |
pubmed-article:10921574 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:10921574 | pubmed:dateCreated | 2000-8-16 | lld:pubmed |
pubmed-article:10921574 | pubmed:abstractText | To evaluate the effect of gut gavage both alone and with enteral administration of monoclonal antibodies to endotoxin on the liberation of tumor necrosis factor (TNF)-alpha and subsequent hemodynamics after hemorrhage/resuscitation. | lld:pubmed |
pubmed-article:10921574 | pubmed:language | eng | lld:pubmed |
pubmed-article:10921574 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10921574 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:10921574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10921574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10921574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10921574 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10921574 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10921574 | pubmed:month | Jul | lld:pubmed |
pubmed-article:10921574 | pubmed:issn | 0090-3493 | lld:pubmed |
pubmed-article:10921574 | pubmed:author | pubmed-author:SutherlandGG | lld:pubmed |
pubmed-article:10921574 | pubmed:author | pubmed-author:GoreD CDC | lld:pubmed |
pubmed-article:10921574 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10921574 | pubmed:volume | 28 | lld:pubmed |
pubmed-article:10921574 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10921574 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10921574 | pubmed:pagination | 2425-8 | lld:pubmed |
pubmed-article:10921574 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:meshHeading | pubmed-meshheading:10921574... | lld:pubmed |
pubmed-article:10921574 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10921574 | pubmed:articleTitle | Gut gavage with antiendotoxin antibodies reduces the liberation of tumor necrosis factor-alpha after hemorrhage/resuscitation. | lld:pubmed |
pubmed-article:10921574 | pubmed:affiliation | Department of Surgery, the University of Texas Medical Branch, Galveston, USA. | lld:pubmed |
pubmed-article:10921574 | pubmed:publicationType | Journal Article | lld:pubmed |